Stock 300534 GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Equities

300534

CNE100002CP5

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
7.17 CNY +2.28% Intraday chart for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD -2.71% -27.36%
30/05 Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024 CI
17/05 Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023
CI
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License
MT
Longshenrongfa Pharma Gets Nod for Proposed Changes in License
MT
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.
CI
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules
MT
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Gansu Longshenrongfa Pharmaceutical Industry CO. ,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Gansu Longshenrongfa Pharmaceutical Industry CO. ,LTD Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd agreed to acquire 46% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd. for approximately CNY 200 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300534 Stock
  4. News Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
  5. Highlights